Noncoding RNAs in Cardiac Hypertrophy and Heart Failure

30Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Heart failure is a major global health concern. Noncoding RNAs (ncRNAs) are involved in physiological processes and in the pathogenesis of various diseases, including heart failure. ncRNAs have emerged as critical components of transcriptional regulatory pathways that govern cardiac development, stress response, signaling, and remodeling in cardiac pathology. Recently, studies of ncRNAs in cardiovascular disease have achieved significant development. Here, we discuss the roles of ncRNAs, including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs) that modulate the cardiac hypertrophy and heart failure.

Cite

CITATION STYLE

APA

Lu, P., Ding, F., Xiang, Y. K., Hao, L., & Zhao, M. (2022, March 1). Noncoding RNAs in Cardiac Hypertrophy and Heart Failure. Cells. MDPI. https://doi.org/10.3390/cells11050777

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free